News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Personnel
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving 8/1/2014
More Drama At Sarepta Therapeutics (SRPT) As Chairman Of The Board Abruptly Steps Down, Interim Chairman Named 8/1/2014
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post 7/31/2014
Astellas Hires Industry Veteran Moyra Knight As Head Of Corporate And Employee Communications 7/31/2014
TB Alliance Names Elana Robertson Senior Vice President, Market Access 7/31/2014
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 7/31/2014
Intra-Cellular Therapies, Inc. Announces The Appointment Of Michael Halstead As Senior Vice President And General Counsel 7/31/2014
Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins Enzo Biochem (ENZ)’s Clinical Division 7/31/2014
Envisia Therapeutics Announces Appointments To Board of Directors 7/31/2014
Franz Och, Ph.D., Expert In Machine Learning And Machine Translation, Joins Human Longevity Inc. As Chief Data Scientist 7/30/2014
Aceto Corporation Appoints Daniel Yarosh, Ph.D. To The Board Of Directors 7/30/2014
Epic Sciences Appoints Greg Lucier As Chairman Of The Board Of Directors 7/30/2014
Thomas Dubinski Joins Dyadic International, Inc. As Chief Financial Officer 7/30/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Appoints Craig Fraser As Chief Operating Officer 7/30/2014
MYOS (MYOS) Announces Appointment Of Douglas Weekes As Chief Commercial Officer 7/30/2014
Celldex Therapeutics, Inc. (CLDX) Announces Senior Leadership Promotions 7/30/2014
Envisia Therapeutics Announces Appointments To Board Of Directors 7/30/2014
Marathon Pharmaceuticals Names Jeanine Swalec Vice President Of Regulatory Affairs 7/30/2014
Rafarma Pharmaceuticals Announces New President As Part Of Pending Acquisition Of Majority Interest 7/30/2014
Polaris Names Ex-Pfizer Inc. (PFE) Exec As Area’s First Female VC Partner 7/29/2014
Boston Therapeutics, Inc. Appoints Zbigniew J. Witczak, Ph.D., To Its Scientific Advisory Board 7/29/2014
Gordon Sangster To Join Codexis, Inc. (CDXS) As Senior Vice President & Chief Financial Officer 7/29/2014
Abide Therapeutics Appoints Nancy Thornberry To Board Of Directors 7/29/2014
MolecularHealth Expands U.S. Sales Team With Three Strategic New Hires 7/29/2014
ISPE Hires Healthcare Association Exec As CEO 7/29/2014
Receptos (RCPT) Announces Appointment Of Mary Szela And Richard Heyman, Ph.D. To Board Of Directors 7/29/2014
Aurinia (ISA.TO) Adds Financial Expertise To Its Board Of Directors 7/29/2014
Management Reshuffle At Ranbaxy Laboratories (RANBAXY.BO): Arno Gessner Promoted, New R&D Head Named 7/28/2014
ELC Group Appoints Head Of Regulatory Affairs For Russia And CIS 7/28/2014
Inform Genomics Announces Appointment Of Carl De Moor, Phd, As Chief Technology Officer 7/28/2014
Arthur J. Tipton, Ph.D., Named President Of Controlled Release Society 7/28/2014
ImaginAb, Inc. Appoints Roger Crystal, MD As Vice President of Business Development 7/28/2014
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors 7/28/2014
Egalet Appoints Jeffrey M. Dayno, M.D. As Chief Medical Officer 7/28/2014
American Diabetes Association Announces Interim CEO 7/28/2014
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval 7/25/2014
Arthur J. Tipton, Ph.D., Named President Of Controlled Release Society 7/25/2014
Tesaro, Inc. (TSRO) Appoints Mary Lynne Hedley, Ph.D., As Chief Operating Officer 7/25/2014
IGI Laboratories, Inc. Announces Change To Its Board Of Directors 7/25/2014
Doyle, Arora Elected; Sterling Reelected To EXACT Sciences Corporation (EXAS)’ Board Of Directors 7/25/2014
Serenus Biotherapeutics Strengthens Leadership With Appointments To Board And Management 7/25/2014
Contract Research Organization WCCT Global Welcomes Peter Nieto As Vice President Of Business Development 7/25/2014
AgeneBio Appoints Industry Leaders Patrick Lepore As Chairman Of The Board And Jerry Mclaughlin As President And Chief Executive Officer 7/25/2014
Bristol-Myers Squibb Company (BMY) Appoints Jitendra Tyagi As India Country Head 7/24/2014
Blueprint Medicines Appoints Jeffrey Albers As Chief Executive Officer 7/24/2014
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw To Executive Officer 7/24/2014
Cypher Genomics Announces The Appointment Of Adam Simpson As President And COO To Advance Transformative Genome Interpretation Technology 7/24/2014
Juventas Therapeutics, Inc. Strengthens Leadership Team By Adding Two Industry Veterans 7/24/2014
Cypher Genomics Appoints To The Board Of Directors, Henry Nordhoff As Executive Chairman And Herbert Boyer And Andrew Von Eschenbach As Directors 7/24/2014
Flexion Therapeutics (FLXN) Announces Board Changes 7/24/2014
Protalix Biotherapeutics, Inc. (PLX) Names Shlomo Yanai As Chairman Of The Board Of Directors 7/24/2014
Cannabis Science Inc. Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (Retired) For A Second Term On The Scientific Advisory Board As Special Senior Advisor To The Company 7/24/2014
GliaCure Appoints New Member To Board Of Directors 7/24/2014
ConMed Corporation (CNMD) Announces Leadership Transition 7/23/2014
Zenith Epigenetics Appoints Julie Cherrington As President And CEO 7/23/2014
bioTheranostics Names Ramesh Hariharan As Vice President Of Marketing 7/23/2014
AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder As Chief Financial Officer 7/23/2014
Ultragenyx Pharmaceuticals (RARE) Appoints Sunil Agarwal, M.D. As Chief Medical Officer And Senior Vice President 7/23/2014
Camargo Pharmaceutical Services Strengthens Research Team And Therapeutic Expertise 7/23/2014
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer 7/22/2014
Viamet Pharmaceuticals Announces Appointment Of Amir Tavakkol, Ph.D., As Chief Development Officer 7/22/2014
BioDelivery Sciences International (BDSI) Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors 7/22/2014
Dr. Neal Rouzier Joins BioTE Medical 7/22/2014
Outcomes and Quality Leader Dr. John D. Birkmeyer Joins Dartmouth-Hitchcock Leadership Team 7/22/2014
Clarus Therapeutics Expands Board of Directors With Appointment Of Two Pharmaceutical Industry Veterans 7/22/2014
Alliqua Biomedical (ALQA) Announces Changes to Its Board Of Directors 7/22/2014
Cutera, Inc. (CUTR) Appoints Miguel Pardos As Executive Vice President Of International 7/22/2014
Flex Pharma Forms Distinguished Scientific Advisory Board 7/21/2014
Arno Therapeutics Appoints Alexander Zukiwski, M.D. As Interim Chief Executive Officer And Mr. Lawrence Kenyon As Chief Operating Officer 7/21/2014
Neogen Corporation (NEOG) COO Resigns 7/21/2014
iBio, Inc. (IBIO) Appoints Dr. Richard M. Silver To Clinical Advisory Board 7/21/2014
JDRF Appoints Derek Rapp As New President & CEO 7/21/2014
Milestone Pharmaceuticals Appoints Chief Medical Officer 7/21/2014
Theranos, Inc. Builds Pioneering Creative Organization, Appoints Patrick O'Neill As Chief Creative Officer 7/21/2014
American Osteopathic Association Installs Cleveland Clinic Executive Robert S. Juhasz, DO, As President 7/21/2014
WCCT Global Release: Contract Research Organization Welcomes Dr. Lani Clark As Head, Dermatology Clinical Research 7/18/2014
BioScrip (BIOS) Appoints Thomas Pettit As Senior Vice President And Chief Operating Officer 7/18/2014
Surpass, Inc. Announces Two Strategic Hires In Silicon Valley Facility And Launch Of Social Media Accounts 7/18/2014
Neurotrope Board Of Directors Appoints Chairmen Ramat And Freiman As Interim Co-CEOs 7/18/2014
Loxo Oncology Expands Leadership Team With Key Executive Appointments In Finance, R&D, And Corporate Development 7/17/2014
Zogenix, Inc. (ZGNX) Announces Appointment Of David Brushwood, J.D., R.Ph., To External Safe Use Board 7/17/2014
Aduro Biotech Names Industry Veteran And Academic Leader, Gerald Chan, DSc To Its Board Of Directors 7/17/2014
James Davis, Biotechnology Consultant, Elected Chair Of The Leukemia & Lymphoma Society's National Board Of Directors 7/17/2014
bluebird bio (BLUE) Appoints Mark Vachon To Its Board Of Directors 7/17/2014
Peptidream Announces The Appointment Of Dr. Keiichi Masuya As Chief Operating Officer (COO) At Peptidream Inc. 7/17/2014
Akebia Therapeutics, Inc. (AKBA) Appoints Michael Clayman, M.D. And Maxine Gowen, Ph.D. To Its Board Of Directors 7/17/2014
Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board 7/17/2014
BioUtah Selects Rich Linder As New Board Chair, George Hamilton As Vice Chair 7/17/2014
Evidera Strengthens European Presence With Senior Leader In Health Economics, Outcomes Research And Market Access 7/17/2014
Depomed, Inc. (DEPO) Announces Appointment Of Srinivas G. Rao, MD, PhD, As Chief Medical Officer 7/16/2014
DS Healthcare Appoints Mark Wolfson To Its Board Of Directors 7/16/2014
Alexion Pharmaceuticals Inc. (ALXN) Announces The Appointments Of David R. Brennan, M. Michele Burns And Christopher J. Coughlin To Its Board Of Directors 7/16/2014
Porter Novelli Appoints Dr. Amy Nicole Nayar Senior Vice President Of Global Health & Wellness 7/16/2014
Entest Biomedical, Inc. Recruits Salk Institute for Biological Studies Researcher To Lead Cancer Stem Cell Program For Treating Feline Leukemia And Canine Cancer 7/16/2014
iBio, Inc. (IBIO) Appoints Dr. Timothy Blackwell To New Clinical Advisory Board 7/16/2014
Aptuit LLC Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities 7/16/2014
MYOS (MYOS) Appoints World Renowned Scientific Visionary And Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors 7/15/2014
Deallus Consulting Appoints New CEO 7/15/2014
Repligen Corporation (RGEN) Hires Jon K. Snodgres As Chief Financial Officer 7/15/2014
ACADIA Pharmaceuticals, Inc. (ACAD)Announces Appointment Of Stephen Davis As Executive Vice President, Chief Financial Officer And Chief Business Officer 7/15/2014
Malini Moorthy Joins Bayer Corporation (BAY) As U.S. Head Of Litigation 7/15/2014
CutisPharma Inc. Appoints Neal Muni, MD, MSPH as President 7/15/2014
Xencor Appoints Kurt Gustafson To Board Of Directors; Promotes John Desjarlais To Chief Scientific Officer 7/15/2014
Washington Biotechnology & Biomedical Association Announces New Appointments To Board Of Directors 7/15/2014
Illumina, Inc. (ILMN) Names Tina S. Nova As Senior Vice President And General Manager Of Oncology 7/15/2014
Mark H.N. Corrigan, M.D., Julie H. McHugh, And William Hunter, M.D. To Serve On EPIRUS Biopharmaceuticals Board Of Directors 7/15/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014
Achaogen (AKAO) Appoints Dr. Ian Friedland As Chief Medical Officer 7/14/2014
Aastrom Biosciences, Inc. (ASTM) Announces Appointment Of Zac Taylor As National Sales Director 7/14/2014
Minerva Neurosciences, Inc. (NERV) Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 7/14/2014
Acceleron Pharma Appoints Terrence C. Kearney To Its Board Of Directors 7/14/2014
Cambridge Startup Jounce Therapeutics Snags Ex-Merck & Co., Inc. (MRK) Exec For CEO Post 7/11/2014
ScinoPharm President & CEO To Retire, Successor Named 7/11/2014
Medivation, Inc. (MDVN) Announces Change In Executive Management Team 7/11/2014
Transition Therapeutics Inc. (TTH.TO) Appoints Carl Damiani As Chief Operating Officer 7/11/2014
MonoSolRx LLC Appoints Joseph Crusco Director Of Business Development 7/10/2014
Intezyne Technologies LLC Expands Executive Leadership Team With Two Key Appointments 7/10/2014
Intercept Pharmaceuticals (ICPT) Names Lazar Partners Agency Of Record 7/10/2014
Vertex Pharmaceuticals (MA) (VRTX) Announces Retirement Of Peter Mueller, Ph.D. 7/10/2014
GlycoMimetics, Inc. (GLYC) Appoints Mark A. Goldberg, M.D. To Board of Directors 7/10/2014
FORUM Pharmaceuticals Appoints Christine Boisclair As Vice President, Regulatory Affairs 7/9/2014
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014
Cellectar Biosciences  (NVLT) Appoints Chad J. Kolean Chief Financial Officer 7/9/2014
Director Ying Han Resigns from WuXi PharmaTech Co., Ltd. Board 7/9/2014
Marken (Formerly known as Marken Time Critical) Appoints Paul J. Rice To Head EMEA Region 7/9/2014
Coherus Biosciences Appoints Dr. V. Bryan Lawlis, Jr. To Board Of Directors 7/9/2014
Professor Paul Workman Joins Nuevolution As Scientific Advisor 7/9/2014
Actavis (ACT) Execs Bag As Much As $186 Million In Merger Success Awards 7/9/2014
RestorGenex Announces Management Changes 7/9/2014
Boston Therapeutics, Inc. Appoints Benjamin Rivnay, Ph.D. To Chief Scientist 7/9/2014
Covance Inc. (CVD) Increases Its Medical And Scientific Leadership With Two Senior-Level Appointments 7/9/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Brings In Ex-Eisai Company, Ltd. (ESALY.PK) Exec As New President And CEO 7/8/2014
Raptor Pharmaceutical Inc. (RPTP) (RPTP) Names COO As Next CEO 7/8/2014
AAIPharma, Inc. Taps Stephan Kutzer As New CEO 7/8/2014
Activist Hedge Fund Proposes Six New Directors For Allergan Inc. (AGN) Board 7/8/2014
Vitae Pharmaceuticals, Inc. Adds To Leadership Team With Appointment Of Arthur Fratamico As Chief Business Officer, Richard Morris As Chief Financial Officer 7/8/2014
Glide Pharma Appoints Richard Bungay As Chief Financial Officer And Tony Mills As Director Of Business Development 7/8/2014
Lead Developer Of RTDS Technology To Take The Helm At Cibus Global 7/8/2014
Michael Balmuth Joins SV Life Sciences As Partner 7/8/2014
Veteran Microsoft Executive And Distinguished Engineer, Sean Nolan, Joins Adaptive Biotechnologies As Chief Technology Officer 7/8/2014
Nobel Laureate Roger Kornberg To Chair New ChromaDex, Inc. Scientific Advisory Board 7/8/2014
Oxford BioTherapeutics Appoints Dr. Eugen Leo As Head Of Clinical Development 7/8/2014
ContraVir Appoints Industry Veteran William Hornung As Its Chief Financial Officer 7/8/2014
Arch Therapeutics Appoints Richard Davis As Chief Financial Officer 7/8/2014
Baylor Oncology Medical Director Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab-B Scientific Advisory Board 7/8/2014
DermTech International Builds Commercialization Team 7/8/2014
Aerie Pharmaceuticals, Inc. (AERI) Expands Management Team, Names Michael McCleerey As Vice President, Marketing 7/8/2014
Baxter International, Inc. (BAX) Names Chief Financial Officers For New Biopharmaceutical Spin-Off And Baxter International Inc. 7/7/2014
StemCells Inc. (STEM) Appoints Dr. Alan Trounson To Board Of Directors 7/7/2014
ISA Pharmaceuticals Appoints Ronald Loggers As Chief Executive Officer 7/7/2014
RXi Pharmaceuticals (RXII) Appoints Peter Campochiaro M.D. To Its Scientific Advisory Board 7/7/2014
La Jolla Pharmaceutical Company (LJPC) Strengthens Board Of Directors With Appointment Of Robert H. Rosen 7/7/2014
Oxford Immunotec Limited (OXFD) Appoints Louis O'Dea Chief Medical Officer 7/7/2014
PCI Welcomes Tim Brown To Clinical Services Group 7/7/2014
Pharmalink AB Strengthens its Board Of Directors 7/7/2014
Diomics Announces New CSO Thomas Kindt, Ph.D. 7/7/2014
Theravance, Inc. (THRX) Appoints Theodore J. Witek, Jr. As Senior Vice President, Corporate Partnerships, Clinical And Medical Affairs 7/3/2014
PDI, Inc. (PDII) Announces Appointment Of Peter Cempellin And Patrick Treacy To Senior Leadership Roles 7/2/2014
Alnylam Pharmaceuticals (ALNY) Elects Amy Schulman To Its Board Of Directors 7/2/2014
Histogenics Corporation Announces Appointment Of Kathleen Large, R.N., M.S., To Vice President Of Clinical Operations 7/2/2014
MOCON Expands Board; Names Two New Directors To Its Board 7/2/2014
BioRestorative Therapies, Inc. Appoints Joseph B. Swiader To Its Board Of Directors 7/2/2014
Gail K. Naughton, PhD To Join Cytori Therapeutics, Inc. (CYTX)’ Board Of Directors 7/2/2014
Aesica Recruits New Business Development Manager To Aid Sales Drive Across German, Austrian And Swiss Markets 7/2/2014
Bellerophon Therapeutics Brings In Ex-Amgen (AMGN) Exec For CEO Post 7/2/2014
Applied Genetic Technologies Corporation Appoints Matthew Feinsod, MD, As Product Development Officer 7/1/2014
Zafgen (ZFGN) Appoints Patrick Loustau As President 7/1/2014
Bacterin International, Inc. Announces The Appointment Of Robert Di Silvio As President 7/1/2014
Paratek Pharmaceuticals, Inc. Taps A New CEO 7/1/2014
ALK-Abello A/S Appoints New Executive Vice President For Product Supply 7/1/2014
Avalanche Biotechnologies Announces Appointment Of Samuel B. Barone, M.D., As Chief Medical Officer 7/1/2014
Batu Biologics Recruits Renowned Cancer Immunologist To Scientific Advisory Board 7/1/2014
Kathy Giusti, Founder And CEO Of Multiple Myeloma Research Foundation (MMRF), Becomes Executive Chairman Of The MMRF Board Of Directors; Walter Capone Becomes President And CEO 7/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Promotion Of Edwin S. Kamemoto, Ph.D. To Senior Vice President, Regulatory Affairs 7/1/2014
Moderna Therapeutics, Inc. Appoints Oncology Leader Dr. Stephen Kelsey As President Of Onkaido Therapeutics 7/1/2014
Kinex Pharmaceuticals Appoints Mr. Michael Murphy To The Board Of Directors 7/1/2014
Actavis plc Appoints New Members And Announces Changes To Board Of Directors Following Close Of Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014
Parkinson's Disease Foundation Announces New Advisory Council Members 7/1/2014
Trevena, Inc. (TRVN) Appoints Julie H. Mchugh And Barbara Yanni To The Board Of Directors 7/1/2014
InVivo Therapeutics Corporation (NVIV) Appoints Christopher McNulty As Vice President, Business Development & Investor Relations 7/1/2014
Proteostasis Therapeutics, Inc. Brings In Meenu Chhabra As CEO 6/30/2014
ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments 6/30/2014
Applied Genetic Technologies Corporation Appoints David R. Guyer, MD, And Ivana Magovcevic-Liebisch, Phd, JD, To Its Board Of Directors 6/30/2014
Ipsen (IPN.PA) Joins PHARNEXT's Board Of Directors 6/30/2014
Nanomix, Inc. Appoints New CFO 6/30/2014
BioRestorative Therapies, Inc. Appoints The Honorable Paul Jude Tonna To Its Board Of Directors 6/30/2014
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. As Chief Medical Officer 6/30/2014
Synthetic Biologics, Inc. (SYN) Forms Clinical Advisory Board to Support Novel C. difficile Preventative Program 6/30/2014
CAPNIA, Inc. Appoints William G. Harris To Its Board Of Directors 6/30/2014
Hurel Corporation Announces Appointment Of Matthew K. Shipton As Head Of Sales And Marketing 6/27/2014
Pressure BioSciences, Inc. (BBII) Engages Issuworks In Strategic Advisory Role 6/27/2014
Zafgen (ZFGN) Appoints New Member Of Board Of Directors 6/27/2014
Chimerix, Inc. (CMRX) Mourns Passing Of Director Rodman L. Drake 6/27/2014
Tatjana Dragovic, J.D., Named Vice President, Regional Compliance Officer For Astellas In The Americas 6/27/2014
NMS Labs Dr. Barry Logan Appointed To National Institute of Standards and Technology Forensic Science Standards Board 6/27/2014
Astellas Appoints Marty Golden, J.D., As Vice President, Government Affairs 6/27/2014
Kolltan Pharmaceuticals Inc. Promotes Jane Henderson To Chief Financial And Business Officer And Expands Senior Team With Appointment Of Keith J. C. Darragh As Vice President Of Finance And Administration 6/27/2014
William Jeffrey Joins SRI International As President And CEO 6/26/2014



//-->